To further investigate the prognostic role of CD68+ TAMs on DSS, the pooled HRs demonstrated no significant association between CD68+ TAMs and DSS in bladder cancer patients (HR = 1.01, 95% CI = 1.00 ~ 1.02) (Figure 2B). Here, CD68 is linked to urinary bladder cancer.